We first identified the CD4+ CTL subset as a unique subset of tumor-infiltrating immune cells in OSCC, characterized by a distinct gene expression pattern including the expression of cytotoxic genes through scRNA-seq analysis with strict quality control, TCR repertoire analysis and SCENIC analysis. This evidence concerns the gene CD4 and neoplasm.